head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2021, vol. 27, issue4
Subject Area: Medicine
DOI: 10.5272/jimab.2021274.4143
Published online: 09 December 2021

Original article

J of IMAB. 2021 Oct-Dec;27(4):4143-4150
Ivica Dimov1ORCID logo Corresponding Autoremail, Mariya Choneva1ORCID logo, Ilia lliev2ORCID logo, Anelia Bivolarska1ORCID logo,
1) Department of Biochemistry, Faculty of Pharmacy, Medical University of Plovdiv, Bulgaria.
2) Department of Biochemistry and Microbiology, Faculty of Biology, Plovdiv University "Paisii Hilendarski", Bulgaria.

Introduction: The purpose of this experiment is to examine the effect of different oligosaccharides with proven prebiotic effects on enzymes of carbohydrate metabolism and the antioxidant protection of erythrocytes in vitro under conditions of hyperglycemia.
Materials and methods: This experiment included 10 healthy men (27±3 years of age). The isolated erythrocytes were treated with 1% and 5% solutions of the following oligosaccharides: lactulose, inulin, galactooligosaccharide and fructooligosaccharide in the presence of 5mM, 50mM and 100mM glucose. After incubation, for 2 hours at 37 °C, the erythrocytes were lysed, and the supernatant was used for analyses of lactate dehydrogenase, hexokinase and glutathione reductase. FRAP (Ferric reducing antioxidant power) method was used for determining the total antioxidant activity of erythrocytes.
Results: Lactate dehydrogenase was decreased in the presence of 5% lactulose in groups with 50mM and 100 mM Glc. An increase in the activity of glutathione reductase under severe hyperglycemia (100mM glucose) was observed after treatment with: 1% lactulose, 1% inulin, 1% galactooligosaccharide, 1% and 5% fructooligosaccharides (p<0.005). A significant difference in the enzymatic activity of hexokinase was found in all groups (p<0.05) and of glutathione reductase only in the control group as well as in the groups treated with 1% lactulose, 1% galactooligosaccharide, 1% and 5% fructooligosaccharides
Conclusions: Galactooligosaccharides 1% and fructooligosaccharides 1% and 5% cause a statistically significant increase of the enzymatic activities of hexokinase and glutathione reductase in in vitro hyperglycemia induced by 100 mM glucose, as well as an increase in FRAP.

Keywords: prebiotics, oligosaccharides, hyperglycemia, erythrocytes, antioxidant protection,

pdf - Download FULL TEXT /PDF 537 KB/
Please cite this article as: Dimov I, Choneva M, lliev I, Bivolarska A. Effect of oligosaccharides on enzymes of carbohydrate metabolism and antioxidant protection in in vitro treated erythrocytes under conditions of hyperglycemia. J of IMAB. 2021 Oct-Dec;27(4):4143-4150.
DOI: 10.5272/jimab.2021274.4143

Corresponding AutorCorrespondence to: Asst. Prof. Ivica Dimov, Department of Biochemistry, Faculty of Pharmacy, Medical University of Plovdiv; 15-A, Vasil Aprilov Blvd., Plovdiv 4002, Bulgaria; E-mail: ivicadimov@gmail.com

1. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microflora - introducing the concept of prebiotics. J Nutr. 1995 Jun;125(6):1401-12. [PubMed]
2. Hashmi A, Naeem N, Farooq Z, Masood S, Iqbal S, Naseer R. Effect of Prebiotic Galacto-Oligosaccharides on Serum Lipid Profile of Hypercholesterolemics. Probiotics Antimicrob Proteins. 2016 Mar;8(1):19-30. [PubMed]
3. Bournet B, Pointreau A, Souque A, N, Muscari F, Lepage B, et al. Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples. Pancreatology. 2012 Jan-Feb;12(1):27-34. [PubMed]
4. De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, et al. Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits. Cell. 2014 Jan 16;156(1-2):84-96. [PubMed]
5. Li L, Ma L, Fu P. Gut microbiota–derived short-chain fatty acids and kidney diseases. Drug Des Devel Ther. 2017 Dec 11;11:3531–3542. [PubMed]
6. Ho J, Reimer RA, Doulla M, Huang C. Effect of prebiotic intake on gut microbiota, intestinal permeability and glycemic control in children with type 1 diabetes: study protocol for a randomized controlled trial. Trials. 2016 Jul 26;17(1):347. [PubMed]
7. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013 Aug 2;341(6145):569-73. [PubMed]
8. Enam F, Mansell TJ. Prebiotics: tools to manipulate the gut microbiome and metabolome. J Ind Microbiol Biotechnol. 2019 Oct;46(9-10):1445-1459. [PubMed]
9. Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, et al. Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods. 2019 Mar 9;8(3):92. [PubMed]
10. Bothe MK, Maathuis AJH, Bellmann S, van der Vossen JMBM, Berressem D, Koehler A, et al. Dose-dependent prebiotic effect of lactulose in a computer-controlled in vitro model of the human large intestine. Nutrients. 2017 Jul 18;9(7):767 [PubMed]
11. Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the efects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009 Mar 1;29(5):508-18. [PubMed]
12. Hansen CH, Frøkiær H, Christensen AG, Bergström A, Licht TR, Hansen AK, et al. Dietary Xylooligosaccharide Downregulates IFN-γ and the Low-Grade Inflammatory Cytokine IL-1β Systemically in Mice. J Nutr. 2013 Apr;143(4):533-40. [PubMed]
13. Ferenczi S, Szegi K, Winkler Z, Barna T, Kovács KJ. Oligomannan Prebiotic Attenuates Immunological, Clinical and Behavioral Symptoms in Mouse Model of Inflammatory Bowel Disease. Scientific Reports. 2016 Sep 23;6:34132. [PubMed]
14. Classification of diabetes mellitus. WHO. 21 April 2019., p.6. [Internet]
15. Viskupicova J, Blaskovic D, Galiniak S, Soszyński M, Bartosz G, Horakova L, et al. Effect of high glucose concentrations on human erythrocytes in vitro. Redox Biol. 2015 Aug;5:381–387. [PubMed]
16. Rajab AM, Haider KH. Hyperglycemia and RBCs: too sweet to survive. Int J Diabetes Dev Ctries. 2018 Feb;38:357-365. [Crossref]
17. Harvey WJ, Kaneko JJ. Glucose metabolism of mammalian erythrocytes. J Cell Physiol. 1976 Oct;89(2):219-24. [PubMed]
18. Mali AV, Bhise SS, Katyare SS, Hegde MV. Altered Kinetics Properties of Erythrocyte Lactate Dehydrogenase in Type II Diabetic Patients and Its Implications for Lactic Acidosis. Indian J Clin Biochem. 2018 Jan;33(1):38‐45. [PubMed]
19. Bhise S, Rao J, Hegde M, Katyare S. Type 2 diabetes differentially affects the substrate saturation kinetic attributes of erythrocyte hexokinase and phosphofructokinase. FEBS Letters. 2020  Jan;594(2):240-250. [PubMed]
20. Skrzep-Poloczek B, Poloczek J, Chełmecka E, Dulska A, Romuk E, Idzik M, et al. The Oxidative Stress Markers in the Erythrocytes and Heart Muscle of Obese Rats: Relate to a High-Fat Diet but Not to DJOS Bariatric Surgery. Antioxidants (Basel). 2020 Feb 22;9(2):183. [PubMed]
21. Ferreira ALA, Machado PEA, Matsubara LS. Lipid peroxidation, antioxidant enzymes and glutathione levels in human erythrocytes exposed to colloidal iron hydroxide in vitro. Braz J Med Biol Res. 1999 Jun;32(6):689-94. [PubMed]
22. Bergmeyer HU, Bernt E. Lactate dehydrogenase. UV-assay with pyruvate and NADH. In: Methods of Enzymatic Analysis. Bergmeyer HU. (Ed.) Academic Press, New York. 1974 pp.574-578.
23. Bergmeyer HU, Grassl M, Walter HE. In Methods of Enzymatic Analysis. 3rd ed., vol. 2, Verlag Chemie, Deerfield Beach, FL, 1983:222-223.
24. Mavis RD, Stellwagen E. Purification and Subunit Structure of Glutathione Reductase From Bakers' Yeast. J Biol Chem. 1968 Feb 25;243(4):809-14. [PubMed]
25. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of ‘‘antioxidant power”: The FRAP assay. Anal Biochem. 1996 Jul 15;239(1):70-6. [PubMed]
26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248-254. [PubMed]
27. Pazzini CEF, Colpo AC, Poetini MR, Pires CF, de Camargo VB, Mendez ASL, et al. Effects of Red Wine Tannat on Oxidative Stress Induced by Glucose and Fructose in Erythrocytes in Vitro. Int J Med Sci. 2015; Jun 1;12(6):478-486. [PubMed]
28. González Flecha FL, Bermúdez MC, Cédola NV, Gagliardino JJ, Rossi JP. Decreased Ca2(+)-ATPase activity after glycosylation of erythrocyte membranes in vivo and in vitro. Diabetes. 1990; Jun;39(6):707-11. [PubMed]
29. Resmi H, Akhunlar H, Temiz Artmann A, Güner G. In vitro effects of high glucose concentrations on membrane protein oxidation, G-actin and deformability of human erythrocytes. Cell Biochem Funct. 2005 May-Jun;23(3):163-8. [PubMed].

Received: 20 January 2021
Published online: 09 December 2021

back to Online Journal